Status of hepatitis B immunization programmes in 1998

Vaccine

Volumn 16, Issue SUPPL., 1998, Pages

  Kane, Mark A ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

CONFERENCE PAPER; ENDEMIC DISEASE; HEALTH PROGRAM; HEPATITIS B; HUMAN; IMMUNIZATION; JAPAN; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; SCANDINAVIA;

HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; NATIONAL HEALTH PROGRAMS; WORLD HEALTH ORGANIZATION;

EID: 0032417858     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00308-9     Document Type: Conference Paper

References (25)

1. World Health Organization: Expanded Programme on Immunization, Global Advisory Group. Week Epidemiol Record 1992;3:11-16.
2. Chen DS, Hsu HM, Chang MH, Sung JL et al. Hepatitis B vaccines: status report on long term efficacy. In: Rizzetto M, Purcell RH, Gerin JL, Verme G, editors. Viral hepatitis and liver disease. Turin: Edizioni Minerva Medica, 1997. p. 635-7.
3. Xu ZY, Cao HL, Liu CB et al. Control of hepatitis B in China. In: Rizzetto M, Purcell RH, Gerin JL, Verme G, editors. Viral hepatitis and liver disease. Turin: Edizioni Minerva Medica, 1997. p. 689-90.
4. Ruff TA, Gertig DM, Otto BF, Gust ID et al. Lombok hepatitis B model immunization project: toward universal infant hepatitis B immunization in Indonesia. J Infect Dis 1995;171:290-6.
5. Chunsuttiwat S, Biggs BA, Maynard J et al. Integration of hepatitis B vaccination into the Expanded Programme on Immunization in Chonburi and Chiangmai provinces, Thailand. Vaccine 1997;15:769-74.
6. Wainwright R, Buklow LR, Parkinson AJ, Zanis C, McMahon BJ. Protection provided by hepatitis B vaccine in a Yupik Eskimo Population: results of a 10-year study. J Infect Dis 1997;175:674-7.
7. Hall AJ. Evaluation of hepatitis B immunization in the Gambia and other developing countries. In: Rizzetto M, Purcell RH, Gerin JL, Verme G, editors. Viral hepatitis and liver disease. Turin: Edizioni Minerva Medica, 1997. p. 684-5.
8. Coursaget P, Leboulleux D, Soumare M, Le Cann P, Yvonnet B, Chiron JP, Coll-Seck AM, Diop-Mar I. Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. J Hepatol 1994;21(2):250-4.
9. Whittle HC, Maine N, Pilkington J et al. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet 1995;345:1089-92.
10. Van Damme P, Kane M, Meheus A. Integration of hepatitis B vaccination into national immunisation programmes. BMJ 1997;5(314):1033-6.
11. Mortimer PP, Miller E. Commentary: antenatal screening and targeting should be sufficient in some countries. BMJ 1997;5(314):1036-7.
12. Roure C. Overview of epidemiology and disease burden of hepatitis B in the European region. Vaccine 1995;13 (Suppl. 1):S18-S21.
13. Hersh BS, Popovici F, Jezek Z, Satten GA, Apetrei RC, Beldescu N, George JR, Shapiro CN, Gayle HD, Heymann DL. Risk factors for HIV infection among abandoned Romanian children. AIDS 1993;7:1617-24.
14. Woodruff BA, Popovici F, Beldescu N, Shapiro CN, Hersh BS. Hepatitis B virus infection among pregnant women in north-eastern Romania. Int J Epidemiol 1993;22(5):923-6.
15. Gatcheva N, Vladimirova N, Kourtchatova A. Implementing universal vaccination programmes: Bulgaria. Vaccine 1995;13 (Suppl. 1):S82-S83.
16. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997;336(26):1855-9.
17. Toukan AU. Hepatitis B in the Middle East: aspects of epidemiology and liver disease after infection. Gut 1996;38 (Suppl. 2):S2-S4.
18. Fay OH, Hadler SC, Maynard JE, Pinheiro F. Hepatitis in the Americas. Pan Am Health Org Bull 1985;19:401-8.
19. National Advisory Committee on Immunization (NACI). Statement on hepatitis B vaccine. Can Commun Dis Rep 1993;19(14):104-15.
20. Centers for Disease Control. Recommended childhood immunization schedule, United States, 1998. MMWR Morb Mortal Wkly Rep 1998;47(1):8-12.
21. Kew MC. Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. Gut 1996;38 (Suppl. 2):S31-S36.
22. Papaevangelou G, Karvelis E, Alexiou D, Kiossoglou K, Roumeliotou A, Safary A, Collard F, Vandepapeliere P. Evaluation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B candidate vaccine administered to healthy infants according to a three-dose vaccination schedule. Vaccine 1995;13(2):175-8.
23. Bruguera M, Bayas JM, Vilella A, Tural C, Gonzalez A, Vidal J, Dal-Re R, Salleras L. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults. Vaccine 1996;14(15):1407-11.
24. West DJ, Hesley TM, Jonas LC, Feeley LK, Bird SR, Burke P, Sadoff JC. Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants. Pediatr Infect Dis J 1997;16(6):593-9.
25. World Bank. World Development Report. 1993.